Preparing the Programme Support Rationale (PSR) for South Sudan (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/preparing-the-programme-support-rationale-psr-for-south-sudan
The Republic of South Sudan (RSS) is a low-income country, still immersed in conflicts, with a fragile state and a complex web of stakeholders. Thus, provision of health services, including vaccinatio
Economic case for Civil Registration and Vital Statistics Systems (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/economic-case-for-civil-registration-and-vital-statistics-systems
The objective of this project is to articulate the economic argument and synthesize the evidence base that show that CRVS systems can provide a valuable return on investment for governments, multilate
Civil Registration and Vital Statisics - CRVS (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/civil-registration-and-vital-statisics-crvs
As one of its major activities, the Civil Registration and Vital Statistics (CRVS) Program of the Bloomberg Philanthropies Data for Health (D4H) initiative supports countries to integrate cause of dea
Evaluation - Girl Effect (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/evaluation-girl-effect
Swiss TPH was mandated to conduct the independent evaluation of the Gavi-Girl Effect Partnership which is aimed at increasing the uptake of HPV vaccination, encouraging broader integrated health seeki
Kinase Inhibitors for Adjunct Antibiotic Treatment of Tuberculosis (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/kinase-inhibitors-for-adjunct-antibiotic-treatment-of-tuberculosis
Tuberculosis (TB) encompasses pulmonary and extra-pulmonary infections by the deadly obligate human pathogen Mycobacterium tuberculosis (MTB). Upon exposure to infectious aerosols, host immune respons
Development and Validation of a Laminar Flow Test to Diagnose COVID-19 in Saliva (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/development-and-validation-of-a-laminar-flow-test-to-diagnose-covid-19-in-saliva
This project addresses the currently crucial needs in the area of validated point-of-care (PoC) diagnostics for use at every level in the population. We developed and validate a simple inexpensive acc
PubliCo - an experimental online platform for COVID-19 related public perception (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/publico-an-experimental-online-platform-for-covid-19-related-public-perception
Effective public health measures to contain the Covid-19 pandemic require cooperation between governments and society. For this to happen, political decision-makers must be aware of how the population
Close the Gap, Increase Access, Provide Adequate Therapy (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/close-the-gap-increase-access-provide-adequate-therapy
Swiss TPH is consortium member in the TB-CAPT project (Close the gap, increase Access, Provide adequate Therapy), which will help improve tuberculosis (TB) diagnosis and management at the point of car
Mitigation strategies for communities with COVID-19 transmission in Lesotho using artificial intelligence on chest x-rays and novel rapid diagnostic... (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/mitigation-strategies-for-communities-with-covid-19-transmission-in-lesotho-using-artificial-intelligence-on-chest-x-rays-and-novel-rapid-diagnostic-tests
The COVID-19 pandemic is straining health systems globally. Public health and primary care interventions implemented by high-income countries may be unsuccessful or infeasible in low- and middle-incom
Using model-based evidence to optimise medical intervention profiles and disease management strategies for COVID-19 control (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/using-model-based-evidence-to-optimise-medical-intervention-profiles-and-disease-management-strategies-for-covid-19-control
During the current COVID-19 pandemic governments have imposed varying social-distance measures, and since 2021 vaccines, to reduce infection incidence and associated disease burden of coronavirus infe